DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vx3f8n/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 - Global Version" report to their offering.
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
"Clinical Laboratory, Molecular Diagnostic and Genomic Testing Services - 2015 to 2019" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand.
Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.
- Changing demographics
- Emerging economies and global prosperity
- Biotechnology advances in genetics
- Pathogen evolution
- Climate change
Key Topics Covered:
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
10. The Future of the Clinical Laboratory
Companies Mentioned - Partial List of the 350+ Companies Featured
- 14M Genomics
- 20/20 GeneSystems
- ACM Medical Laboratory
- ACT Genomics
- ARUP Laboratories, Inc.
- Abbott Diagnostics
- Accelerate Diagnostics
- Acibadem Labmed Laboratory
- Adaptive Biotechnologies
- Adarza BioSystems
- Adicon Clinical Laboratories, Inc.
- Advanced Cell Diagnostics
- Aegis Sciences
- Aeris Capital
- Aetna Innovation Lab
- Agena Bioscience
- Alberta Investment Management
- Alere Inc
- Allegro Dx
- Alliance Global
- Amarantus BioScience
- American Liberty Petroleum
For more information visit http://www.researchandmarkets.com/research/vx3f8n/clinical